Feb 06, 2020
Queensland Department of Health chooses Philips QuestLink to enhance patient outcome and experience measurements
Automated digital patient survey tool collects real-time patient outcome and experience data provided back to health service clinicians for the implementation of quality improvement initiatives at local and State-wide levels
Philips QuestLink helps enable shared decision-making between patients and clinicians and optimise the quality of treatment and care provided to patients
Sydney, Australia – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Queensland Health has selected Philips QuestLink digital patient outcomes management software for the State’s public hospitals. Philips QuestLink is a digital solution that collects, processes and analyses patient reported outcome measures and the experience of care measures. Via comprehensive dashboards, the software provides rich insight into treatment outcomes, patient-reported history and recovery and satisfaction data, with the aim to inform the most effective course of care. The software places the patient experience at the core and offers a digital solution focused on outcomes to deliver relevant input for shared decision support between clinicians and patients. Philips was one of the first to receive the ICHOM Certified Supplier Status by the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organisation with the mission to transform healthcare systems worldwide by measuring and reporting patient outcomes in a standardised manner. “The journey to delivering value-based care starts with understanding long-term outcomes. We are excited to partner with Queensland Health as a world-class health system placing the patients at the centre of care,” said Matt Moran, Managing Director, Philips Australia and New Zealand. “We strongly believe that patient engagement solutions are an effective way to ensure the patient's voice is included as part of their care journey for a higher quality of care.”
Two of the other topics identified in the Future Health Index 2019 report include:
Features of Philips QuestLink include: For more information on QuestLink, the patient engagement applications that support online collaboration between care providers and patients, click here.
Empowered patients – access to data, more control
The Future Health Index indicates that giving patients access to their own health data makes them more likely to engage with it in a way that will improve the quality of care they receive and their overall healthcare experience. Of Australians that have access to their Digital Health Records, over half rate themselves as proactive when it comes to their health. Those who don't have access to their record are less likely to rate themselves as such. However, people need to be clear on how to use their data, with a third of those who have access more likely to use it if they knew it could make managing their health easier. “In Australia, while some individuals are hesitant, many want to be empowered and have access to their digital health records,” said Matt Moran. “The benefits of this access are clear with patients feeling more empowered and in control of their health journey.” The Future Health Index 2019 has indicated that putting the patient at the centre of the healthcare experience will deliver better health outcomes, lowering the cost of care and supporting Australia to accelerate the move towards value-based care. Since 2016, Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective health systems. Details on the methodology and a full list of sources are available here. To read the full report, download the Future Health Index 2019 Australia country report.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
